M
MDXG
Mimedx Group Inc
3.870
-0.160-3.97%After Hours: 3.860 -0.010 -0.26%19:46 04/10 EDT
OPEN/PREV CLOSE4.040/4.030
TODAY RANGE3.845-4.070
VOL966.21K
MARKET CAP574.95M
52 WEEK RANGE3.770-7.99
AVG VOL (3M)1.07M
% TURNOVER0.65%
TURNOVER--
P/E (TTM)11.93
% RANGE5.58%
EPS(TTM)0.3244
P/E(FORWARD)45.53
P/B2.234
BVPS1.732
DIVIDEND--
P/S1.369
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP561.50M
SHARES OUTSTANDING148.57M
NEXT EARNINGS04/28-05/04
FREE FLOAT145.09M
LOT SIZE1
EX-DATE04/02/2008
News
Press Releases
Financial Reports
Profile
TipRanks·03/05 13:20
MiMedx announces commercial launch of AMNIOFIX Thyroid Shields
Reuters·03/05 13:02
MiMedx Launches AMNIOFIX Thyroid Shields for Endocrine Surgery
TipRanks·02/26 14:55
Northland Securities Sticks to Their Buy Rating for MiMedx Group (MDXG)
NASDAQ·02/26 00:25
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
Benzinga·02/25 21:26
Earnings Summary: MiMedx Group Q4
Reuters·02/25 21:19
MiMedx beats Q4 sales estimates; announces $100 mln share buyback
TipRanks·02/25 21:05
MiMedx sees FY26 revenue $340M-$360M, consensus $356.17M
Reuters·02/25 21:03
MiMedx posts FY 2025 net sales of USD 418.6 million, up 20%